EMERGE HEALTH INTERNATIONAL INC

CIK:0000032567|SEC Filings
v3.21.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
CONSOLIDATED STATEMENTS OF OPERATIONS    
Gross sales $ 0 $ 1,938,222
Cost of sales 0 1,304,551
Gross profit 0 633,671
Operating expenses 91,217 1,087,963
Research and development 2,235,593 6,375
Total operating expenses 2,326,810 1,094,338
Net loss from operations (2,326,810) (460,667)
Other Income (expense)    
Interest (27,706) (25,635)
Total Other Income (expense) (27,706) 4,170
Net income (loss) before taxes (2,354,516) (21,465)
Income taxes 0 0
Net Loss (2,354,516) (482,132)
Loss from discontinued operations (1,462,790) 0
Net Loss $ (3,817,306) $ (482,132)
Loss from operations    
Basic loss per share $ (0.15) $ 0.03
Weighted number of shares outstanding 17,797,685 17,766,647
Loss from discontinued operations    
Basic loss per share $ 0.02 $ 0.00
Weighted number of shares outstanding 17,797,685 17,766,647